2 studies on ACTH(4-10) curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Bottom line: TitrateLab currently curates 2 dated studies on ACTH(4-10). The source summaries below describe published research; they do not establish product quality, safety, or clinical suitability.
The findings demonstrate that the free N-terminal amino group of Semax is indispensable for its neuroprotective activity against copper-induced toxicity. For users, this implies that **acetylated Semax (Ac-Semax) is n…
The findings suggest a potential therapeutic role for Semax in mitigating the neurodevelopmental side effects associated with perinatal SSRI exposure. For individuals concerned about the long-term impact of in-utero o…
Free, no account — handy when you're working with ACTH(4-10).
Pro members save studies and unlock the full evidence breakdown and vendor lab data.
Buyer protection: Wrong or defective product? Report it within 7 days. We broker a refund or reship with the vendor.
$14 monthly or $88/year
Create an account